Venus Concept (Venus Concept) Net Margin % : -61.31% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Venus Concept Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Venus Concept's Net Income for the three months ended in Dec. 2023 was $-11.12 Mil. Venus Concept's Revenue for the three months ended in Dec. 2023 was $18.13 Mil. Therefore, Venus Concept's net margin for the quarter that ended in Dec. 2023 was -61.31%.

The historical rank and industry rank for Venus Concept's Net Margin % or its related term are showing as below:

VERO' s Net Margin % Range Over the Past 10 Years
Min: -140.04 Med: -83.78 Max: -21.79
Current: -48.79

VERO's Net Margin % is ranked worse than
69.41% of 814 companies
in the Medical Devices & Instruments industry
Industry Median: -0.41 vs VERO: -48.79

Venus Concept Net Margin % Historical Data

The historical data trend for Venus Concept's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Concept Net Margin % Chart

Venus Concept Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-36.79

-104.73

-21.79

-43.92

-48.79

Venus Concept Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %	Get a 7-Day Free Trial															-40.83	-47.04	-36.91	-51.48	-61.31

Competitive Comparison of Venus Concept's Net Margin %

For the Medical Devices subindustry, Venus Concept's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Venus Concept's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Concept's Net Margin % distribution charts can be found below:

* The bar in red indicates where Venus Concept's Net Margin % falls into.

Venus Concept Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Venus Concept's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-37.25	/	76.354
	=	-48.79 %

Venus Concept's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-11.116	/	18.132
	=	-61.31 %

Venus Concept (NAS:VERO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Venus Concept Net Margin % Related Terms

Thank you for viewing the detailed overview of Venus Concept's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Venus Concept (Venus Concept) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Concept Inc (NAS:VERO) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

235 Yorkland Boulevard, Suite 900, Toronto, ON, CAN, M2J 4Y8

Website

https://www.venusconcept.com

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Heal, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Executives

Anthony Natale	director	235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8
Ross Portaro	officer: President Global Sales	235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8
Michael Willingham Masters	10 percent owner	3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Silva Rajiv De	director, officer: Chief Executive Officer	1400 ATWATER DRIVE, MALVERN PA 19355
Stanley Tyler Hollmig	director	235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8
Hemanth Jacob Varghese	officer: President/Chief Bus. Officer	330 JOICEY BOULEVARD, TORONTO A6 M5M2W1
Marlin Fund, Limited Partnership	10 percent owner	MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Masters Capital Management Llc	10 percent owner	3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Marlin Fund Iii, Limited Partnership	10 percent owner	MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Marlin Master Fund Offshore Ii, Lp	10 percent owner	WAYSTONE CORP SV (CAYMAN) LTD, STE 5B201, FL 2, 1 NEXUS WAY, CAMANA BAY, BOX 1344, GRAND CAYMAN E9 KY1-1108
Mss Vc Spv Lp	10 percent owner	C/O MASTERS SPECIAL SITUATIONS, LLC, 3060 PEACHTREE ROAD, NW, STE.1425, ATLANTA GA 30305
Marlin Fund Ii, Limited Partnership	10 percent owner	MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Masters Special Situations, Llc	10 percent owner	3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Penna Domenic Della	officer: Chief Financial Officer	235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8
Anna Georgiadis	officer: VP, Global HR	235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8